Skip to content

Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies (MULAN)

Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies: a Retrospective Cohort

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04732546
Acronym
MULAN
Enrollment
1000
Registered
2021-02-01
Start date
2000-01-01
Completion date
2050-12-31
Last updated
2023-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mullerian Anomaly of Cervix, Mullerian Anomaly of Uterus, Nec, Mullerian Anomaly of Vagina

Keywords

Mullerian anomaly, Diagnostic tools, Surgical treatment, Reproductive function, Obstetric complications

Brief summary

The purpose of this study is to get a better understanding of the clinical implications (including reproductive problems and obstetric complications), appropriate diagnostic tools and correct surgical treatment of Mullerian anomalies.

Detailed description

Mullerian anomalies are rare, therefore they are not well known and not often considered as differential diagnosis. This causes a delay in the diagnosis with risk of long lasting symptoms and adverse effects on the reproductive function. However, the diagnosis can be made more accurately with improved diagnostic tools. Moreover, minimally invasive surgery allows for preservation and potential improvement of fertility in these women. The purpose of this study is to get a better understanding of the clinical implications (including reproductive problems and obstetric complications), appropriate diagnostic tools and correct surgical treatment of Mullerian anomalies.

Interventions

None listed

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 45 Years
Healthy volunteers
No

Inclusion criteria

* women with a uterus * presence of a mullerian variation * Maximum age 45y

Exclusion criteria

* women without a uterus * aged \>45y

Design outcomes

Primary

MeasureTime frameDescription
Fertility10 years after trying to conceiveTime to clinical pregnancy
Surgical approachduring surgeryDifferent surgical approaches used
Surgical success15 years after surgeryRelief of symptoms after surgery

Secondary

MeasureTime frameDescription
Diagnostic accuracyat the time of diagnostic workupThe ability of a test to detect a Mullerian variation when it is present and detect the absence of a Mullerian variation when it is absent
Obstetric complications1 year after conceptionComplications during pregnancy, labor, delivery, and the postpartum period

Countries

Belgium

Contacts

Primary ContactEline Meireson
eline.meireson@uzgent.be093327817

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026